Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Merck & Co. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value increased by 1.2% to $244.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $241.00M to $244.00M. Over 5 years (FY 2020 to FY 2025), Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value shows a downward trend with a -4.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Higher values indicate that a significant portion of vested options are 'in-the-money,' which may lead to imminent share issuance.
Detailed definition
This metric represents the aggregate intrinsic value of all vested and exercisable stock options. It measures the immedi...
Peer comparison
Standard metric for assessing the immediate value of vested employee equity.
other_sharebased_compensation_arrangement_by_sharebased__feb020Historical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $198.00M | $399.00M | $379.00M | $241.00M | $244.00M |
| QoQ Change | — | +101.5% | -5.0% | -36.4% | +1.2% |
| YoY Change | — | +101.5% | -5.0% | -36.4% | +1.2% |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value?
- Merck & Co. (MRK) reported share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value of $244.00M in Q4 2025.
- How has Merck & Co.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value changed year-over-year?
- Merck & Co.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value increased by 1.2% year-over-year, from $241.00M to $244.00M.
- What is the long-term trend for Merck & Co.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value?
- Over 5 years (2020 to 2025), Merck & Co.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value has grown at a -4.6% compound annual growth rate (CAGR), from $309.00M to $244.00M.
- What does share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value mean?
- The total paper profit of all vested stock options if they were exercised at today's market price.